Benoit Destenaves, PharmD

Executive Director - Head of Biomarkers and Companion Dx at H3 Biomedicine
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Greater Boston, US
Languages
  • French Native or bilingual proficiency
  • English Native or bilingual proficiency
Skills

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Experience

  • H3 Biomedicine
    • United States
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Executive Director - Head of Biomarkers and Companion Dx
      • Oct 2019 - Present

      Leading H3 Biomedicine's team in charge of clinical translational medicine, patient selection and diagnostic development. Leading H3 Biomedicine's team in charge of clinical translational medicine, patient selection and diagnostic development.

  • AstraZeneca
    • United Kingdom
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Director, Precision Medicine Lead
      • Aug 2016 - Oct 2019

      Accountable for defining and implementing precision medicine strategies for AstraZeneca oncology drugs.Represent PMG function on global project teams.Lead strategic AstraZeneca collaborations related to diagnostics and genomics.

    • Director, Pharmacogenomics and Molecular Diagnostics Labs
      • May 2013 - Aug 2016

      Led a team of 20 scientists supporting AZ drug development through: - Evaluating diagnostic technology platforms- Setup, QC and Monitoring of prospective patient testing. 90% oncology-related with a strong focus on novel approaches: ctDNA, NGS. Led company-level strategic projects.

  • Healthcare Business of Merck
    • Germany
    • Pharmaceutical Manufacturing
    • 300 - 400 Employee
    • Director, Head of biomarkers & personalized medicine - Endocrinology & Fertility
      • Jul 2010 - Apr 2013

      Led translational science strategy for the fertility and endocrinology therapeutic areas.

    • Associate director oncology pharmacogenomics and biomarkers
      • Jun 2008 - Jun 2010

      Definition and implementation of translational and pharmacogenomics strategies in oncology drug development programs

  • Serono
    • Pharmacogenomics Project Manager
      • Jun 2004 - May 2008

      Established a structure to support pharmacogenomics activities in phase I-IV clinical trials.Managed pharmacogenomics projects in oncology, endocrinology, and fertility. Established a structure to support pharmacogenomics activities in phase I-IV clinical trials.Managed pharmacogenomics projects in oncology, endocrinology, and fertility.

  • Genset SA
    • Data Scientist
      • Jan 2001 - May 2004

      Genomic data mining. Genomic data mining.

  • Genset S.A.
    • Pharmacogenomics Scientist
      • Oct 2000 - Dec 2000

      Business development scientific support. Business development scientific support.

Education

  • Paris-Sud University (Paris XI)
    PharmD., Pharmacy
    1993 - 2000

Community

You need to have a working account to view this content. Click here to join now